|
|
|
|
LEADER |
02268 am a22003253u 4500 |
001 |
71762 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Chahrour, Maria H.
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Research Laboratory of Electronics
|e contributor
|
100 |
1 |
0 |
|a Schubert, Christian R.
|e contributor
|
100 |
1 |
0 |
|a Schubert, Christian R.
|e contributor
|
700 |
1 |
0 |
|a Yu, Timothy W.
|e author
|
700 |
1 |
0 |
|a Lim, Elaine T.
|e author
|
700 |
1 |
0 |
|a Ataman, Bulent
|e author
|
700 |
1 |
0 |
|a Coulter, Michael E.
|e author
|
700 |
1 |
0 |
|a Hill, R. Sean
|e author
|
700 |
1 |
0 |
|a Stevens, Christine R.
|e author
|
700 |
1 |
0 |
|a Schubert, Christian R.
|e author
|
700 |
1 |
0 |
|a Greenberg, Michael E.
|e author
|
700 |
1 |
0 |
|a Gabriel, Stacey B.
|e author
|
700 |
1 |
0 |
|a Walsh, Christopher A.
|e author
|
245 |
0 |
0 |
|a Whole-Exome Sequencing and Homozygosity Analysis Implicate Depolarization-Regulated Neuronal Genes in Autism
|
260 |
|
|
|b Public Library of Science,
|c 2012-07-23T18:55:57Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/71762
|
520 |
|
|
|a Although autism has a clear genetic component, the high genetic heterogeneity of the disorder has been a challenge for the identification of causative genes. We used homozygosity analysis to identify probands from nonconsanguineous families that showed evidence of distant shared ancestry, suggesting potentially recessive mutations. Whole-exome sequencing of 16 probands revealed validated homozygous, potentially pathogenic recessive mutations that segregated perfectly with disease in 4/16 families. The candidate genes (UBE3B, CLTCL1, NCKAP5L, ZNF18) encode proteins involved in proteolysis, GTPase-mediated signaling, cytoskeletal organization, and other pathways. Furthermore, neuronal depolarization regulated the transcription of these genes, suggesting potential activity-dependent roles in neurons. We present a multidimensional strategy for filtering whole-exome sequence data to find candidate recessive mutations in autism, which may have broader applicability to other complex, heterogeneous disorders.
|
520 |
|
|
|a National Institutes of Health (U.S.) (Grant no. T32 NS007473-11)
|
520 |
|
|
|a National Institutes of Health (U.S.) (Grant no. T32 NS007484-11)
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t PLoS Genetics
|